Table 2 Pharmacists' Inquiries and Recommendations in Response to the Simulated Clinical Scenarios
From: Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: A Cross Sectional Study
Simulated clinical scenario | Recommended medical evaluation (%) (95% CI) | Asked about associated symptoms (%) (95% CI) | Asked about presence of fever (%) (95% CI) | Asked about pregnancy status (%) (95% CI) | Dispensed antibiotic |
|---|---|---|---|---|---|
Sore throat (n = 58) | 5% (1.1%-14.4%) | 40% (27.0% -53.4%) | 9% (2.9%-19.0%) | NA | Amoxicillin/Clavulanate (60%) Azithromycin (20%) Amoxicillin (17%) Others (3%) |
Acute bronchitis (n = 44) | 14% (5.2%-27.4%) | 43% (28.3%-59.0%) | 25% (13.2%-40.3%) | NA | Amoxicillin/Clavulanate (42%) Amoxicillin (27%) Azithromycin (15%) Others (16%) |
UTI (n = 58) | 10% (3.9%-21.2%) | 22% (12.5%-35.3%) | 14% (6.1%-25.4%) | 23% (12.5%-35.3%) | Ciprofloxacin (86%) Amoxicillin (7%) Cefixime (2%) Clarithromycin (2%) Others (3%) |
Diarrhea (n = 59) | 3% (0.4%-11.7%) | 62% (49.1%-75.0%) | 14% (6.0%-23.0%) | NA | Metronidazole (89%) Ciprofloxacin (5%) Cotrimoxazole (2%) Ofloxacin (2%) Others (2%) |
Acute sinusitis (n = 55) | 2% (0.0-9.7%) | 73% (59.0%-83.9) | 9% (3.0%-20.0%) | NA | Amoxicillin/Clavulanate (58%) Azithromycin (26%) Amoxicillin (8%) Cefaclor (3%) Ofloxacillin (3%) Others (2%) |
Otitis media (n = 53) | 47% (33.3% -61.4%) | 19% (8.3%-29.4%) | 2% (0.0-10.1) | NA | Amoxicillin/Clavulanate (44%) Amoxicillin (29%) Cephalexin (15%) Azithromycin (4%) Cefaclor (4%) Cefixime (4%) |